Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22090469 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial
Condition: Metabolic Syndrome X
Interventions: Drug: Telmisartan (Micardis®) vs. Placebo;   Behavioral: Low-Glycemic Index Diet vs. Control Diet

Indicates status has not been verified in more than two years